<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28545">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735122</url>
  </required_header>
  <id_info>
    <org_study_id>CO-151027203834-PACT</org_study_id>
    <nct_id>NCT02735122</nct_id>
  </id_info>
  <brief_title>Study of Acetaminophen (ACM) in Post-operative Dental Pain</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy, Safety, and Pharmacokinetics Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Consumer Inc., McNeil Consumer Healthcare Division</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johnson &amp; Johnson Consumer and Personal Products Worldwide</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Consumer and Personal Products Worldwide</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Dental Pain Study which will evaluate the analgesic onset, efficacy and safety of
      1000 mg acetaminophen as two Test acetaminophen 500 mg tablets, compared with commercial
      products of acetaminophen 1000 mg administered as two 500 mg tablets, and ibuprofen (IBU)
      400 mg following third molar (wisdom tooth) extraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-dose, randomized, double-blind, triple-dummy, placebo- and active
      controlled, parallel-group study to evaluate the analgesic onset, efficacy, and safety
      profile of Test ACM 1000 mg compared with two commercial products over a six-hour period
      after third-molar extractions. Subjects will undergo dental extraction of three or four
      third molars.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">March 30, 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first confirmed perceptible pain relief</measure>
    <time_frame>6 hours</time_frame>
    <description>Minutes until confirmed first perceptible pain relief are achieved. Stopwatch is started after the subject takes the study medication. The subject is instructed to stop the stopwatch when they first begin to feel any pain relief. The first perceptible pain relief is confirmed if the subject also stopped the second stopwatch indicating meaningful pain relief.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with confirmed perceptible relief from 30 minutes to successively earlier minutes in one-minute increments (Test ACM versus placebo)</measure>
    <time_frame>30 minutes or less</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk ratios of confirmed perceptible relief by 10 minutes (Test acetominophen and commercial ibuprofen)</measure>
    <time_frame>10 minutes or less</time_frame>
    <description>The risk ratios and confidence intervals for incidence of confirmed perceptible relief of Test ACM divided by commercial IBU will be presented for 10 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk ratios of confirmed perceptible relief by 15 minutes (Test acetominophen and commercial ibuprofen)</measure>
    <time_frame>15 minutes or less</time_frame>
    <description>The risk ratios and confidence intervals for incidence of confirmed perceptible relief of Test ACM divided by commercial IBU will be presented for 15 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk ratios of confirmed perceptible relief by 20 minutes (Test acetominophen and commercial ibuprofen)</measure>
    <time_frame>20 minutes or less</time_frame>
    <description>The risk ratios and confidence intervals for incidence of confirmed perceptible relief of Test ACM divided by commercial IBU will be presented for 20 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with meaningful relief by 30 minutes</measure>
    <time_frame>30 minutes or less</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to meaningful pain relief</measure>
    <time_frame>6 hours</time_frame>
    <description>Minutes until meaningful pain relief are achieved. Stopwatch is started after the subject takes the study medication. The subjects are instructed to stop the stopwatch when the relief from the starting pain is meaningful to them.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">420</enrollment>
  <condition>Tooth Extraction Status Nos</condition>
  <arm_group>
    <arm_group_label>Test acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test acetaminophen1000-mg dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Commercial acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercial acetaminophen 1000 mg dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Commercial ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercial ibuprofen 400 mg dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Test acetaminophen</intervention_name>
    <description>2 Test acetaminophen 500 mg tablets, 2 placebo caplets, and 2 placebo liquid-filled capsules</description>
    <arm_group_label>Test acetaminophen</arm_group_label>
    <other_name>Test ACM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Commercial acetaminophen</intervention_name>
    <description>2 acetaminophen 500 mg caplets, 2 placebo tablets, and 2 placebo liquid-filled capsules</description>
    <arm_group_label>Commercial acetaminophen</arm_group_label>
    <other_name>Commercial ACM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Commercial ibuprofen</intervention_name>
    <description>2 ibuprofen 200 mg soft-gels, 2 placebo tablets, and 2 placebo caplets</description>
    <arm_group_label>Commercial ibuprofen</arm_group_label>
    <other_name>Commercial IBU</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Comparator</intervention_name>
    <description>2 placebo tablets, 2 placebo caplets, and 2 placebo liquid-filled capsules</description>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 17 years to 50 years old

          2. Weight 100 lbs or greater with a body mass index (BMI) 18-30 inclusive

          3. Dental extraction of three or four molars

          4. Experience moderate to severe pain after extraction of third molars

          5. Females of childbearing age must be willing to use acceptable method of birth control

        Exclusion Criteria:

          1. Currently pregnant or planning to be pregnant or nursing a baby

          2. Known allergy to acetaminophen (ACM) or non-steroidal anti-inflammatory drugs
             (NSAIDS)

          3. Inability to swallow whole large tablets or capsules

          4. Have other conditions that the investigator feels may impact subject's safety and/or
             the integrity of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Jean Brown Research</name>
      <address>
        <city>Salt Lake City, UT 84124</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jean Brown Research</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 7, 2017</lastchanged_date>
  <firstreceived_date>March 31, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
